Abstract
In this month's drug focus, Mee Onn Chai and Adrian Coleman discuss a case of hypomagnesaemia associated with omeprazole use in a 68-year-old male with chronic kidney disease stage 5. The article outlines the indications, mechanisms of action and adverse effects of this proton pump inhibitor. It also suggests possible alternatives to this form of treatment where this is appropriate for patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
